20Jan 2017

Drug Compliance among Type 2 Diabetic patients in Jazan Region, Saudi Arabia.

  • Faculty of Medicine, Jazan University.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Although adherence to prescribed medications is a key dimension of healthcare quality, there is no information about the magnitude of compliance of the diabetic patients in Jazan region of Saudi Arabia. Objectives: The purpose of this study is to measure the rate of adherence and the factors contributing to compliance among the diabetic patients in Jazan region.Methods: A total of 273 Type 2 diabetic patients who fulfill the inclusion criteria were recruited in the study. Adherence to the treatment was evaluated during patients’ attending to the usual appointment in the randomly selected Primary Health Care centers and Diabetic Centers in Jazan region. The medication adherence was assessed during a personal interview using the 8-item Morisky Medication Adherence Scale (MMAS-8).Results:Twenty Three Percent of patients reported good medication adherence, 38.8 % medium adherence and 37.6 % poor medication adherence. The factors significantly associated with adherence in univariate analysis were socio-demographic factors: residence ( p = 0.02) and distance from the health care center ( p = 0.023 ); disease and health care related factors: Regularly attending to the appointments (p= 0.038) and HbA1c >8 ( p= 0.06 ).Conclusion: The findings indicate that there is a high rate of non-compliance among the diabetes patients in Jazan region of Saudi Arabia and there is a definite need for improvement in the healthcare system, health education, and training of diabetic patients.

  1. R. Guide, “Care of the Patient with Diabetes Mellitus,” no. June, 2009.
  2. P. Guidelines, “of Diabetes,” vol. 32, no. September, 2008.
  3. Diabetes Atlas, second ed. International Diabetes Federation, Brus- sels, 2003.
  4. Tiv, J.-F. Viel, F. Mauny, E. Eschwège, A. Weill, C. Fournier, A. Fagot-Campagna, and A. Penfornis, “Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study.,” PloS one, vol. 7, no. 3, p. e32412, Jan. 2012.
  5. Osterberg and T. Blaschke, “Adherence to medication.,” The New England journal of medicine, vol. 353, no. 5, pp. 487–97, Aug. 2005.
  6. a Al-Qasem, F. Smith, and S. Clifford, “Adherence to medication among chronic patients in Middle Eastern countries: review of studies.,” Eastern Mediterranean health journal = La revue de santé de la Méditerranée orientale = al-Majallah al-?i???yah li-sharq al-mutawassi?, vol. 17, no. 4, pp. 356–63, Apr. 2011.
  7. E. E. Shams and E. a. M. E. Barakat, “Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt,” Saudi Pharmaceutical Journal, vol. 18, no. 4, pp. 225–232, Oct. 2010.
  8. Jin, G. E. Sklar, V. Min, and S. Oh, “Factors affecting therapeutic compliance?: A review from the patient ’ s perspective,” vol. 4, no. 1, pp. 269–286, 2008.
  9. a Hedtke, “Can wireless technology enable new diabetes management tools?,” Journal of diabetes science and technology, vol. 2, no. 1, pp. 127–30, Jan. 2008.
  10. M. Sweileh, O. Aker, and S. Hamooz, “Rate of Compliance among Patients with Diabetes Mellitus and Hypertension Abstract?: Introduction and Aims?: Patient compliance or adherence is defined as the extent to which a,” vol. 19, pp. 1–12, 2005.
  11. R. Khan, Z. N. Al-Abdul Lateef, M. a Al Aithan, M. a Bu-Khamseen, I. Al Ibrahim, and S. a Khan, “Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia.,” Journal of family & community medicine, vol. 19, no. 1, pp. 26–32, Jan. 2012.
  12. Manuscript, “NIH Public Access,” vol. 90, no. 2, pp. 216–221, 2011.
  14. Kasznicki, “Type 2 diabetic patients compliance with drug therapy and glycaemic control,” pp. 17–19.
  15. Lertmaharit, P. Kamol-Ratankul, H. Sawert, S. Jittimanee, and S. Wangmanee, “Factors associated with compliance among tuberculosis patients in Thailand.,” Journal of the Medical Association of Thailand = Chotmaihet thangphaet, vol. 88 Suppl 4, no. 1, pp. S149–56, Sep. 2005.
  16. N. Kalyango, E. Owino, and A. P. Nambuya, “Non-adherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors.,” African health sciences, vol. 8, no. 2, pp. 67–73, Jun. 2008.

[Taha Alhazmi, Jaber Sharahili, Shadi Khurmi, Turki Zughbi, Mariam Alrefai, Mohammed Hakami, Fahad Wasili, Mamdouh S. Wadani, Albaraa Sahli, Abdulrahman H. Alhazmi, Sattam Jaddoh. (2017); Drug Compliance among Type 2 Diabetic patients in Jazan Region, Saudi Arabia. Int. J. of Adv. Res. 5 (1). 966-974] (ISSN 2320-5407). www.journalijar.com

Adham Ahmed
Faculty of Medicine, Jazan University.


Article DOI: 10.21474/IJAR01/2838       DOI URL: http://dx.doi.org/10.21474/IJAR01/2838

Share this article